Despite progress in our understanding of the biology of hepatocellular carcinoma (HCC), this tumour remains difficult-to-cure for several reasons, starting from the particular disease environment where it arises-advanced chronic liver disease-to its heterogeneous clinical and biological behaviour. The advent, and good results, of immunotherapy...
-
2019 (v1)PublicationUploaded on: April 14, 2023
-
2018 (v1)Publication
Prognostic assessment of patients with hepatocellular carcinoma (HCC) at the time of diagnosis remains controversial and becomes even more complex at the time of restaging when new variables need to be considered. The aim of the current study was to evaluate the prognostic utility of re-staging patients before proceeding with additional...
Uploaded on: April 14, 2023 -
2023 (v1)Publication
No description
Uploaded on: February 6, 2024